RxDoctor Payments DataLook up a doctor →

Amitabh Goswami

Interventional Pain Medicine · Fresno, CANPI 1447451539

Payments from drug & device makers

$250,286in general payments, 2019–2025

Across 1,299 payments — averaging $192.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$152K
  • Boston Scientific$76K
  • Painteq LLC$9K
  • Relievant Medsystems, Inc.$2K
  • Nalu Medical, Inc.$2K
  • Abbott$2K
  • plus $6K from 45 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$16

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Spinal Simplicity, LLC19$152,372
Boston Scientific673$76,277
Painteq LLC186$9,177
Relievant Medsystems, Inc.35$2,372
Nalu Medical, Inc.79$2,125
Abbott29$1,807
Medtronic(2 entities)29$982
Teva Pharmaceuticals USA, Inc.45$737
AbbVie(2 entities)28$603
Vertiflex, Inc.16$524
Nevro Corp.14$514
Scilex Pharmaceuticals Inc.23$327
SPR Therapeutics, Inc22$271
Zyla Life Sciences, Inc.24$211
Pfizer5$166
Globus Medical2$155
Arbor Pharmaceuticals, Inc.8$139
Si-bone, Inc.4$119
Hydrocision, Inc.1$102
Saluda Medical Americas, Inc.2$102
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$98
Vertos Medical, Inc.3$84
Collegium Pharmaceutical, Inc.5$84
Inari Medical, Inc.1$83
Vertex3$67
Merz Pharmaceuticals, LLC3$66
Idorsia Pharmaceuticals US Inc1$63
Almatica Pharma LLC3$63
Indivior Inc.3$54
Kowa Pharmaceuticals America, Inc.1$53
Stryker2$48
Biohaven Pharmaceutical Holding Company Ltd.2$45
Radius Health, Inc.2$34
Masimo Corporation2$33
Curonix LLC2$30
Alkermes, Inc.1$29
Gilead1$29
Merz North America, Inc.2$28
Azurity Pharmaceuticals, Inc.1$25
Pacira Pharmaceuticals Incorporated1$23
Novartis1$20
Amgen1$19
Neuronetics, Inc.1$18
Pacira Therapeutics, Inc.1$18
GRT US Holding, Inc.1$17
Lilly USA, LLC1$15
Axonics, Inc.1$13
Bioventus LLC1$13
Medline Industries LP1$12
Assertio Therapeutics, Inc.1$12
Biodelivery Sciences International, Inc.1$11

How this compares

$250,286 in reported general payments places this provider in the 90th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Medicare billing

Part B allowed, 2024
$1,428,184
Medicare patients
964
Services billed
31,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional pain medicine in Fresno

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →